The in vivo interaction between flavone acetic acid and hyperthermia

被引:21
作者
Horsman, MR [1 ]
Sampson, LE [1 ]
Chaplin, DJ [1 ]
Overgaard, J [1 ]
机构
[1] MT VERNON HOSP, CANC RES TRUST, GRAY LAB, NORTHWOOD HA6 2JR, MIDDX, ENGLAND
关键词
hyperthermia; flavone acetic acid; C3H mouse mammary carcinoma; normal foot skin; tumour necrosis factor;
D O I
10.3109/02656739609027684
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vivo interaction between flavone acetic acid (FAA) and hyperthermia was studied in a C3H mammary carcinoma grown in the feet of female CDF1 mice and in normal foot skin. FAA was intraperitoneally injected prior to local tissue heating in restrained non-anaesthetized animals. Alone, FAA at doses of 100 mg/kg and above, inhibited tumour growth in a dose-dependent fashion. FAA also enhanced the tumour response to heat, the effect being dependent on both the time interval between the two modalities and the FAA dose, the greatest effect occurring when FAA doses of greater than or equal to 150 mg/kg preceeded heat by 3-48 h. These effects of FAA correlated with the drug's ability to decrease tumour blood perfusion measured using the RbCl extraction procedure. Injecting 150 mg/kg FAA 3 h before heating (42.7 degrees C) resulted in a 2.2-fold increase in tumour heat damage, but had little effect on the response of normal foot skin in non-tumour-bearing mice. However, this treatment gave a 2.0-fold increase in normal tissue damage when the skin experiments were repeated in tumour-bearing animals. These effects in skin occurred in the absence of any blood perfusion changes, but appeared to be associated with FAA-induced TNF-alpha production.
引用
收藏
页码:779 / 789
页数:11
相关论文
共 47 条
[1]  
[Anonymous], 1979, TUMOR BLOOD CIRCULAT
[2]   REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J].
BIBBY, MC ;
DOUBLE, JA ;
LOADMAN, PM ;
DUKE, CV .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) :216-222
[3]   FACTORS INVOLVED IN THE ANTICANCER ACTIVITY OF THE INVESTIGATIONAL AGENTS LM985 (FLAVONE ACETIC-ACID ESTER) AND LM975 (FLAVONE ACETIC-ACID) [J].
BIBBY, MC ;
DOUBLE, JA ;
PHILLIPS, RM ;
LOADMAN, PM .
BRITISH JOURNAL OF CANCER, 1987, 55 (02) :159-163
[4]   ANTIPROLIFERATIVE PROPERTIES OF FLAVONE ACETIC-ACID (NSC-347512) (LM-975), A NEW ANTICANCER AGENT [J].
CAPOLONGO, LS ;
BALCONI, G ;
UBEZIO, P ;
GIAVAZZI, R ;
TARABOLETTI, G ;
REGONESI, A ;
YODER, OC ;
DINCALCI, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (10) :1529-1535
[5]  
CORBETT TH, 1986, INVEST NEW DRUG, V4, P207
[6]  
CRILE G, 1963, CANCER RES, V23, P372
[7]   THE USE OF HYDRALAZINE TO MANIPULATE TUMOR TEMPERATURES DURING HYPERTHERMIA [J].
DEWHIRST, MW ;
PRESCOTT, DM ;
CLEGG, S ;
SAMULSKI, TV ;
PAGE, RL ;
THRALL, DE ;
LEOPOLD, K ;
ROSNER, G ;
ACKER, JC ;
OLESON, JR .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1990, 6 (06) :971-983
[8]   INDUCTION OF HYPOXIA IN THE KHT SARCOMA BY TUMOR-NECROSIS-FACTOR AND FLAVONE ACETIC-ACID [J].
EDWARDS, HS ;
BREMNER, JCM ;
STRATFORD, IJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1991, 59 (02) :419-432
[9]  
EVELHOCH JL, 1988, CANCER RES, V48, P4749
[10]   EFFECT OF FLAVONE ACETIC-ACID ON LEWIS LUNG-CARCINOMA - EVIDENCE FOR AN INDIRECT EFFECT [J].
FINLAY, GJ ;
SMITH, GP ;
FRAY, LM ;
BAGULEY, BC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (04) :241-245